Artesunate (Test) + Artesunate (Comparator)

Phase 1Completed
0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Hype Score

Development Stage

Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Falciparum Malaria

Conditions

Falciparum Malaria

Trial Timeline

Jun 1, 2009 → Aug 1, 2009

About Artesunate (Test) + Artesunate (Comparator)

Artesunate (Test) + Artesunate (Comparator) is a phase 1 stage product being developed by Pfizer for Falciparum Malaria. The current trial status is completed. This product is registered under clinical trial identifier NCT00894374. Target conditions include Falciparum Malaria.

What happened to similar drugs?

3 of 5 similar drugs in Falciparum Malaria were approved

Approved (3) Terminated (0) Active (2)

Hype Score Breakdown

Clinical
6
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00894374Phase 1Completed